| Register | Login | Search | Contact Us | Terms of Use | ||||||
![]() |
|
|
Please install Flash and turn on Javascript. |
|
Tools and Resources
Bitter Melon
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
| General Info | ||||||||||
|
Active Forms Absorption Dietary Sources |
||||||||||
| Dosage Info | Back to Top | |||||||||
|
||||||||||
| Overview | Back to Top | |||||||||
|
||||||||||
| Toxicities & Precautions | Back to Top | |||||||||
|
General No toxicity is reported in recommended dosages. Health Conditions Do not use in individuals with existing liver disease including alcoholic cirrhosis.(6) Pregnancy/Breast-Feeding Based on animal data, do not use in pregnancy due to abortifacient activity.(7) If nursing, consult a physician before use. Age Limitations Do not use in children under 2 years of age unless recommended by a physician. |
||||||||||
| Symptoms & Causes of Deficiency | ||||||||||
| Footnotes | Back to Top | |||||||||
|
1 Zhu ZJ, et al. Studies on the active constituents of Momordica charantia L. Yao Hsueh Hsueh Pao. 1990;25(12):898-903.
View Abstract 2 Khanna P, et al. Hypoglycemic Activity of Polypeptide-P From a Plant Source. J Nat Prod. Nov1981; 44(6):648-55. View Abstract 3 Lee-Huang S, et al. Anti-HIV and Anti-Tumor Activities of Recombinant MAP30 From Bitter Melon. Gene. Aug1995;161(2):151-56. View Abstract 4 Leatherdale BA, et al. Improvement in Glucose Tolerance Due to Momordica Charantia (Karela). Br Med J. (Clin Res Ed). Jun1981;282(6279):1823-24. View Abstract 5 Day C, Cartwright T, Provost J, et al. Hypoglycaemic Effect of Momordica charantia Extracts. Planta Med. Oct1990;56(5):426-9. View Abstract 6 Tennekoon KH, et al. Effect of Momordica Charantia on Key Hepatic Enzymes. J Ethnopharmacol. Oct1994;44(2):93-97. View Abstract 7 Leung SO, et al. The Immunosuppressive Activities of Two Abortifacient Proteins Isolated From the Seeds of Bitter Melon (Momordica charantia). Immunopharmacology. Jun1987;13(3):159-71. View Abstract |
||||||||||